HOME >> MEDICINE >> NEWS
NIH awards funding to biotech firm for heart disease

ugment conventional therapies such as artery bypass grafting and angioplasty. Ateriocyte's unique combination of blood cell types has shown encouraging results in animal studies.

Laughlin is director of the Allogeneic Transplant Program at University Hospitals of Cleveland and associate professor of medicine and pathology at Case Western Reserve University. Pompili is director of Interventional Cardiology at University Hospitals of Cleveland and associate professor of medicine and director of coronary care services at Case Western Reserve University. The company is based on technologies developed by the founders and Steven Haynesworth, associate dean of the College of Arts and Sciences at Case. Don Brown, a former executive of Viacell and Schering-Plough, is the company's chief executive officer. The university invested $250,000 in Arteriocyte through its Case Technology Ventures fund.

The grant is part of the NIH's Small Business Technology Transfer Award program, which is designed to help the transfer of innovative technologies from an academic setting to the commercial sector and rapidly translate research discoveries made in the laboratory into therapy for patients.

Blocked or damaged blood vessels are a major cause of illness and death around the world. Atherosclerosis, for example, can lead to congestive heart failure and heart attacks. About 5 million people in the U. S. have heart failure and the number is growing. Each year, another 550,000 people are diagnosed for the first time. It contributes to or causes about 300,000 deaths each year. About 1 percent of the U.S. population over the age of 65 is diagnosed with congestive heart failure each year. Existing therapies include drugs, gene therapy, and vascular interventions for relief of arterial obstructions. In 2003, approximately 750,000 coronary artery bypass graft (CABG) surgeries were performed worldwide and approximately 1.8 million balloon angioplasty procedures were perfor
'"/>

Contact: George Stamatis
George.Stamatis@case.edu
216-368-3635
Case Western Reserve University
25-Apr-2005


Page: 1 2 3

Related medicine news :

1. University hospitals wins multiple national IT awards for electronic patient data bank
2. CIRM awards $3.79 million to Burnham Institute
3. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
4. Gerontological Society of America awards new Hartford Doctoral Fellowships
5. AACR awards minority and other underrepresented scientists
6. FNSNA awards $25,000 grant to Rutgers College of Nursing
7. International and American Associations for Dental Research present awards and fellowships
8. JDRF awards Emory $2.5 million to develop islet transplant technology
9. NIH awards $1 million to Temple University Hospital for neurological treatment studies
10. NHLBI awards 12 Womens Health Initiative contracts
11. The Gerontological Society of America awards new Hartford Doctoral Fellowships

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIH awards funding biotech firm for heart disease

(Date:3/31/2015)... (PRWEB) March 31, 2015 As the ... Fitness is pledging to have a mobile-friendly website online ... is part of Chunk Fitness’ continued commitment to bring ... growing user base. All of the same great fitness ... it will be substantially easier to read while browsing ...
(Date:3/31/2015)... CA (PRWEB) March 31, 2015 Cosmetic ... on the Internet, is proudly enduring adding news to ... doctors and the consumers of plastic surgery and cosmetic ... more user-friendly pages and interconnected sections, the Cosmetic Town ... newest addition to the Cosmetic Town site navigation, News ...
(Date:3/31/2015)... 31, 2015 In conjunction with ... April 1-7, the Mesothelioma Applied Research Foundation (Meso ... program, to complement its existing work in mesothelioma ... part of the Meso Foundation’s mission, we want ... diseases related to asbestos, including mesothelioma,” said the ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 In ... (ADS) is offering advice for buying from a ... Dealers Association (NMEDA) is a nonprofit organization that ... in the manufacturing and installation of mobility equipment. ... in the industry that consistently adhere to the ...
(Date:3/31/2015)... March 31, 2015 Calling all runners, walkers ... and other tick-borne diseases! The first annual “Lyme Walk & ... Park in Stamford, CT. The event, hosted by Lyme ... will raise funds to support research and education about Lyme ... to all ages and abilities, will feature 5K and 10K ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town is Now Transforming so Consumer can Better Navigate 2Health News:Mesothelioma Research Organization Announces New Prevention Program 2Health News:Mesothelioma Research Organization Announces New Prevention Program 3Health News:Advanced Driving Systems Celebrates National Disability Month 2Health News:Lyme Research Alliance & Tick-Borne Disease Alliance to Kick-Off 1st “Lyme Walk & Run” Event, April 26 2
(Date:3/31/2015)...  Dr. Renu Razdan of leading Indian CRO ... Congress in April to discuss the latest, progressive announcement regarding ... drugs below: India,s Drugs ... Health that if a new drug is approved and marketed ... India with waiver of clinical trial ...
(Date:3/31/2015)... ALPHARETTA, Ga. , March 31, 2015   ... Health Care, today announced it was awarded a new ... line of face masks. Effective March 1, 2015, Halyard,s ... masks with SO SOFT* lining, will be available to ... as well as 15,000 ambulatory surgery centers, physician practices ...
(Date:3/31/2015)... NEW YORK , March 31, 2015 ... ) announced today that it intends to expand its ... fully human monoclonal antibody targeting eotaxin-1. Bullous Pemphigoid is ... approximately 60,000 patients in the US and ... expects to start enrolling patients in a Phase II ...
Breaking Medicine Technology:Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2Halyard Health Signs First GPO Contracts As Independent Company 2Halyard Health Signs First GPO Contracts As Independent Company 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4
Cached News: